Union City, CA, United States of America

Lian Mo

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Aluda Pharmaceuticals, Inc.. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lian Mo. Retrieved from https://idiyas.com/inventor/lian-mo-qu249cjl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lian Mo: Innovator in Pharmaceutical Chemistry

Introduction

Lian Mo is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on s-triazine compounds. With a total of 2 patents, his inventions focus on developing drugs that target critical health issues.

Latest Patents

Lian Mo's latest patents include a 2,4,6-trisubstituted s-triazine compound, along with its preparation method and applications. This invention provides a compound represented by a general formula, which can be utilized in creating drugs aimed at preventing or treating diseases linked to protein kinase and vimentin dysregulation, as well as cell vacuolization. Notably, these compounds are particularly relevant for developing treatments for cancer growth and metastasis, tissue fibrosis, and atherosclerosis.

Career Highlights

Throughout his career, Lian Mo has worked with several prominent companies in the pharmaceutical industry. He has been associated with Aluda Pharmaceuticals, Inc. and Nanjing Shiqi Pharmaceutical Co. Ltd., where he has contributed to various research and development projects.

Collaborations

Lian Mo has collaborated with several professionals in his field, including Qizheng Yao and Jianping Wu. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Lian Mo's work in developing s-triazine compounds represents a significant advancement in pharmaceutical chemistry. His contributions are poised to impact the treatment of serious health conditions, showcasing the importance of innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…